CVS Health Corporation $CVS Shares Purchased by IFP Advisors Inc

IFP Advisors Inc lifted its position in CVS Health Corporation (NYSE:CVS) by 3.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,118 shares of the pharmacy operator’s stock after purchasing an additional 862 shares during the quarter. IFP Advisors Inc’s holdings in CVS Health were worth $1,664,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in CVS. GAMMA Investing LLC lifted its position in CVS Health by 198.5% during the 1st quarter. GAMMA Investing LLC now owns 18,669 shares of the pharmacy operator’s stock worth $1,265,000 after acquiring an additional 12,415 shares during the period. Simon Quick Advisors LLC acquired a new stake in CVS Health during the 1st quarter worth approximately $543,000. Fifth Third Bancorp lifted its holdings in shares of CVS Health by 4.6% in the 1st quarter. Fifth Third Bancorp now owns 169,749 shares of the pharmacy operator’s stock valued at $11,500,000 after buying an additional 7,410 shares during the period. GPS Wealth Strategies Group LLC lifted its holdings in shares of CVS Health by 37.5% in the 1st quarter. GPS Wealth Strategies Group LLC now owns 1,761 shares of the pharmacy operator’s stock valued at $119,000 after buying an additional 480 shares during the period. Finally, Krilogy Financial LLC acquired a new stake in shares of CVS Health in the 1st quarter valued at approximately $1,046,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Stock Performance

CVS Health stock opened at $77.89 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The stock has a fifty day moving average of $72.28 and a two-hundred day moving average of $67.67. The company has a market capitalization of $98.79 billion, a price-to-earnings ratio of 21.76, a PEG ratio of 0.86 and a beta of 0.60. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $79.20.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.CVS Health’s revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a $0.665 dividend. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s payout ratio is currently 74.30%.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Wells Fargo & Company raised their price target on CVS Health from $84.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday. Mizuho raised their price target on CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a report on Thursday. Robert W. Baird raised CVS Health from a “neutral” rating to an “outperform” rating and raised their price target for the company from $71.00 to $82.00 in a report on Thursday, August 14th. UBS Group raised CVS Health from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $67.00 to $79.00 in a report on Monday, August 18th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $78.00 price objective on shares of CVS Health in a report on Tuesday, August 26th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus price target of $79.80.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.